COVID-19 Monoclonal Antibodies: Feasible Mechanisms for Generating Needed Evidence
Published date
December 10, 2020
Duke-Margolis Affiliated Authors
Mark McClellan, MD, PhD
Director of the Duke-Margolis Institute for Health Policy
Robert J. Margolis, MD, Professor of Business, Medicine and Policy
Margolis Executive Core Faculty
